These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16239206

  • 1. Oncogenic osteomalacia cured by removal of an organized hematoma.
    Colt E, Gopan T, Chong HS.
    Endocr Pract; 2005; 11(3):190-3. PubMed ID: 16239206
    [Abstract] [Full Text] [Related]

  • 2. Tumor-induced osteomalacia. Evidence of a surgically correctable alteration in vitamin D metabolism.
    Parker MS, Klein I, Haussler MR, Mintz DH.
    JAMA; 1981 Feb 06; 245(5):492-3. PubMed ID: 7452873
    [Abstract] [Full Text] [Related]

  • 3. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM, Lyles KW, Harrelson JM, Friedman NE, Drezner MK.
    J Clin Invest; 1985 Jun 06; 75(6):1858-68. PubMed ID: 3839245
    [Abstract] [Full Text] [Related]

  • 4. Hypophosphatemic rickets/osteomalacia in linear sebaceous nevus syndrome: a variant of tumor-induced osteomalacia.
    Carey DE, Drezner MK, Hamdan JA, Mange M, Ahmad MS, Mubarak S, Nyhan WL.
    J Pediatr; 1986 Dec 06; 109(6):994-1000. PubMed ID: 3023599
    [Abstract] [Full Text] [Related]

  • 5. Noninvasive testing in the diagnosis of osteomalacia.
    Bingham CT, Fitzpatrick LA.
    Am J Med; 1993 Nov 06; 95(5):519-23. PubMed ID: 7646591
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK, Lyles KW, Haussler MR, Harrelson JM.
    J Clin Invest; 1980 Nov 06; 66(5):1020-32. PubMed ID: 6253520
    [Abstract] [Full Text] [Related]

  • 7. [Oncogenic osteomalacia in a 49-year-old female patient].
    Ludwig J, Mechtersheimer G, Haberkorn U, Nawroth P, Schilling T, Kasperk C.
    Dtsch Med Wochenschr; 2005 Feb 04; 130(5):206-9. PubMed ID: 15678388
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D metabolism in hypophosphatemic rickets.
    Mason RS, Rohl PG, Lissner D, Posen S.
    Am J Dis Child; 1982 Oct 04; 136(10):909-13. PubMed ID: 6981996
    [Abstract] [Full Text] [Related]

  • 9. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F, Minisola S, Sgueglia M, Blasi S, Brunelli D, Degli Effetti E, Maturo A, Cola A, Custureri F, Campana FP.
    G Chir; 2006 Oct 04; 27(1-2):9-13. PubMed ID: 16608626
    [Abstract] [Full Text] [Related]

  • 10. Tumor-induced osteomalacia: clinical and basic studies.
    Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL.
    J Bone Miner Res; 1997 Sep 04; 12(9):1502-11. PubMed ID: 9286768
    [Abstract] [Full Text] [Related]

  • 11. Studies in a patient with tumor-induced hypophosphatemic osteomalacia.
    Ryan WG, Gitelis S, Charters JR.
    Calcif Tissue Int; 1986 Jun 04; 38(6):358-62. PubMed ID: 3089559
    [Abstract] [Full Text] [Related]

  • 12. August 2003: 47-year-old female with a 7-year history of osteomalacia and hypophosphatemia.
    Reis-Filho JS, Paiva ME, Lopes JM.
    Brain Pathol; 2004 Jan 04; 14(1):111-2, 115. PubMed ID: 14997944
    [Abstract] [Full Text] [Related]

  • 13. A patient with primary hyperparathyroidism associated with osteomalacia: markedly increased serum levels of intact PTH and 1,25-dihydroxyvitamin D with normo- and hypercalcemia.
    Takemia T, Sato K, Miyata M, Imaki T, Shibasaki T, Tsushima T, Demura H, Tanaka R, Obara T, Oguchi S.
    Endocr J; 1993 Feb 04; 40(1):121-6. PubMed ID: 7951485
    [Abstract] [Full Text] [Related]

  • 14. Cinacalcet in the management of tumor-induced osteomalacia.
    Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT.
    J Bone Miner Res; 2007 Jun 04; 22(6):931-7. PubMed ID: 17352646
    [Abstract] [Full Text] [Related]

  • 15. 1 alpha,25-dihydroxyvitamin D3 corrects osteomalacia in hypoparathyroidism and pseudohypoparathyroidism.
    Epstein S, Meunier PJ, Lambert PW, Stern PH, Bell NH.
    Acta Endocrinol (Copenh); 1983 Jun 04; 103(2):241-7. PubMed ID: 6687971
    [Abstract] [Full Text] [Related]

  • 16. Tumor-induced osteomalacia.
    Schapira D, Ben Izhak O, Nachtigal A, Burstein A, Shalom RB, Shagrawi I, Best LA.
    Semin Arthritis Rheum; 1995 Aug 04; 25(1):35-46. PubMed ID: 8525389
    [Abstract] [Full Text] [Related]

  • 17. Oncogenic vitamin D resistant hypophosphatemic osteomalacia (benign ossifying mesenchymal tumor of bone): case report.
    Uchida H, Yokoyama S, Kashima K, Nakayama I, Shimizu K, Masumi S.
    Jpn J Clin Oncol; 1991 Jun 04; 21(3):218-26. PubMed ID: 1942553
    [Abstract] [Full Text] [Related]

  • 18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Jun 04; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 19. [Hypophosphatemic oncogenic osteomalacia].
    Mátyus J, Szebenyi B, Rédl P, Mikita J, Gáspár L, Haris A, Radó J, Kakuk G.
    Orv Hetil; 2000 Dec 17; 141(51):2785-8. PubMed ID: 11196239
    [Abstract] [Full Text] [Related]

  • 20. Development of tertiary hyperparathyroidism after phosphate supplementation in oncogenic osteomalacia.
    Huang QL, Feig DS, Blackstein ME.
    J Endocrinol Invest; 2000 Apr 17; 23(4):263-7. PubMed ID: 10853715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.